Parkman Healthcare Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-30,037
Closed -$11.2M 99
2024
Q2
$11.2M Buy
+30,037
New +$10.1M 1.5% 24
2024
Q1
Sell
-18,081
Closed -$8.28M 107
2023
Q4
$8.28M Sell
18,081
-3,230
-15% -$1.59M 1.17% 30
2023
Q3
$10.4M Buy
21,311
+10,151
+91% +$4.77M 1.9% 13
2023
Q2
$4.99M Sell
11,160
-6,677
-37% -$3.36M 0.87% 36
2023
Q1
$8.66M Buy
17,837
+398
+2% +$197K 1.88% 20
2022
Q4
$8.93M Buy
+17,439
New +$9.17M 2.38% 11
2021
Q4
Sell
-19,000
Closed -$7.39M 88
2021
Q3
$7.39M Sell
19,000
-13,681
-42% -$5.81M 1.87% 21
2021
Q2
$14.5M Sell
32,681
-319
-1% -$139K 3.16% 8
2021
Q1
$13.8M Buy
33,000
+8,192
+33% +$3.27M 3.21% 6
2020
Q4
$10.2M Sell
24,808
-1,701
-6% -$707K 2.61% 9
2020
Q3
$11M Sell
26,509
-3,491
-12% -$1.4M 2.91% 6
2020
Q2
$11.6M Buy
+30,000
New +$11.2M 3.28% 6

Other funds holding HUM

Parkman Healthcare Partners's HUM Position: Q3 2024 in Review

Parkman Healthcare Partners sold out of Humana (HUM) in Q3 2024, closing a stake of 30,037 shares — an estimated $11.2M sold.

Parkman Healthcare Partners first reported a position in HUM in Q2 2020 and held it in 12 quarters. The position peaked at $14.5M in Q2 2021. 940 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

  • Parkman Healthcare Partners reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 30,037 Humana shares in Q3 2024, an estimated $11.2M.
  • Parkman Healthcare Partners first reported a position in Humana in Q2 2020 and held it in 12 quarters.
  • Parkman Healthcare Partners's Humana position peaked at $14.5M in Q2 2021.
  • 940 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.